|
 |
|
 |
|
|
Mercury, Vaccines, and Autism, Revisted
|
An expert on mercury at John Hopkins University's Bloomberg School of
Public Health says that much heartache in the thimerosal-in-vaccines
controversy could have been avoided if U.S. health authorities had
taken measures during the 1990s to limit the use of thimerosal. Such a
decision should have been made at least by 1997, when the Environmental
Protection Agency issued its report to Congress on mercury, says Ellen
K. Silbergeld, Ph.D. in an extebded letter-to-the editor in the American Journal of Public Health, August 2008.
Dr. Silbergeld notes there was a model for more prudent preventative action in the early 1970s when the FDA encouraged the food industry
to stop sealing cans with lead (another known toxin). She says the industry was encouraged, "without a
prolonged debate on whether this specific use was associated with
specific neutoxic outcomes in children."
The author was commenting on a recent article in the journal, titled "Mercury, Vaccines and Autism: One Controversy, Three Histories."
(Baker, JP,Am J Public Health 2008:98:244-353).
Link to the AJPH to access the full letter ($15):
http://www.ajph.org/cgi/content/full/98/8/1350
Index to related information on this site.
7-21-08
|
|
|
 |
|
 |
|
 |
|